Exelixis Insider Trades
NASDAQ: EXELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 24 · $31.75M
- Shares bought / sold
- 0 / 698.37K
- Net activity
- Net selling $31.8 million
Exelixis insider activity
Over the last 12 months, Exelixis insiders reported 66 transactions on SEC Form 4: 0 open-market purchases and 24 sales. Insiders bought $0 and sold $31.8 million worth of stock, for net insider selling of $31.8 million. The largest seller was Aftab Dana, with $5.6 million in reported sales.
The most recent filing shows Beckerle Mary C (Director) selling 9,812 shares at $53.66 on Aug 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put EXEL's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
EXEL insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 10, 2026 | Beckerle Mary CDirector | Sale | 9,812 | $526.51K | Form 4 |
| Jun 1, 2026 | WYSZOMIERSKI JACK LDirector | Sale | 3,925 | $198.41K | Form 4 |
| Jun 1, 2026 | Eckhardt Sue GailDirector | Sale | 9,812 | $491.97K | Form 4 |
| May 27, 2026 | WYSZOMIERSKI JACK LDirector | Award | 8,367 | — | Form 4 |
| May 27, 2026 | Oliver BobDirector | Award | 8,367 | — | Form 4 |
| May 27, 2026 | Beckerle Mary CDirector | Award | 8,367 | — | Form 4 |
| May 27, 2026 | POSTE GEORGEDirector | Award | 8,367 | — | Form 4 |
| May 27, 2026 | Freire Maria CDirector | Award | 8,367 | — | Form 4 |
| May 27, 2026 | Smith JulieDirector | Award | 8,367 | — | Form 4 |
| May 27, 2026 | PAPADOPOULOS STELIOSDirector | Award | 8,367 | — | Form 4 |
| May 27, 2026 | Eckhardt Sue GailDirector | Award | 8,367 | — | Form 4 |
| May 27, 2026 | Heyman Tomas J.Director | Award | 8,367 | — | Form 4 |
| May 26, 2026 | Aftab DanaEVP, Research and Development | Sale | 43,451 | $2.19M | Form 4 |
| May 20, 2026 | Haley Patrick J.EVP, Commercial | Sale | 32,110 | $1.60M | Form 4 |
| May 18, 2026 | Hefti BrendaSVP and General Counsel | Sale | 6,625 | $332.64K | Form 4 |
| May 18, 2026 | MORRISSEY MICHAELPresident and CEO | Gift | 124,047 | — | Form 4 |
| May 18, 2026 | MORRISSEY MICHAELPresident and CEO | Gift | 124,047 | — | Form 4 |
| May 18, 2026 | Senner Christopher J.EVP and CFO | Sale | 34,901 | $1.75M | Form 4 |
| May 15, 2026 | Hefti BrendaSVP and General Counsel | Tax withholding | 6,411 | $327.60K | Form 4 |
| May 15, 2026 | Haley Patrick J.EVP, Commercial | Tax withholding | 33,265 | $1.70M | Form 4 |
| May 15, 2026 | MORRISSEY MICHAELPresident and CEO | Tax withholding | 128,497 | $6.57M | Form 4 |
| May 15, 2026 | Aftab DanaEVP, Research and Development | Tax withholding | 30,578 | $1.56M | Form 4 |
| May 15, 2026 | Senner Christopher J.EVP and CFO | Tax withholding | 40,892 | $2.09M | Form 4 |
| May 7, 2026 | Beckerle Mary CDirector | Sale | 7,712 | $373.65K | Form 4 |
| May 7, 2026 | Beckerle Mary CDirector | Option exercise | 3,856 | $89.61K | Form 4 |
| May 7, 2026 | POSTE GEORGEDirector | Sale | 60,000 | $2.74M | Form 4 |
| May 7, 2026 | Freire Maria CDirector | Sale | 20,634 | $949.16K | Form 4 |
| May 7, 2026 | Freire Maria CDirector | Option exercise | 20,634 | $407.93K | Form 4 |
| May 6, 2026 | MORRISSEY MICHAELPresident and CEO | Gift | 109,676 | — | Form 4 |
| Feb 26, 2026 | Haley Patrick J.EVP, Commercial | Award | 40,459 | — | Form 4 |
| Feb 26, 2026 | Aftab DanaEVP, Research and Development | Award | 52,018 | — | Form 4 |
| Feb 26, 2026 | Senner Christopher J.EVP and CFO | Award | 52,018 | — | Form 4 |
| Feb 26, 2026 | MORRISSEY MICHAELPresident and CEO | Award | 160,437 | — | Form 4 |
| Feb 26, 2026 | Hefti BrendaSVP and General Counsel | Award | 23,119 | — | Form 4 |
| Feb 24, 2026 | Aftab DanaEVP, Research and Development | Sale | 47,918 | $2.13M | Form 4 |
| Feb 24, 2026 | MORRISSEY MICHAELPresident and CEO | Gift | 100,278 | — | Form 4 |
| Feb 19, 2026 | Aftab DanaEVP, Research and Development | Sale | 29,873 | $1.32M | Form 4 |
| Feb 18, 2026 | Hefti BrendaSVP and General Counsel | Sale | 18,669 | $821.62K | Form 4 |
| Feb 18, 2026 | MORRISSEY MICHAELPresident and CEO | Gift | 125,094 | — | Form 4 |
| Feb 18, 2026 | MORRISSEY MICHAELPresident and CEO | Gift | 125,094 | — | Form 4 |
| Feb 18, 2026 | Smith JulieDirector | Sale | 20,030 | $887.33K | Form 4 |
| Feb 18, 2026 | Smith JulieDirector | Option exercise | 20,030 | $434.45K | Form 4 |
| Feb 18, 2026 | Smith JulieDirector | Sale | 44,087 | $1.96M | Form 4 |
| Feb 18, 2026 | Smith JulieDirector | Option exercise | 44,087 | $854.85K | Form 4 |
| Feb 18, 2026 | WYSZOMIERSKI JACK LDirector | Sale | 99,574 | $4.38M | Form 4 |
| Feb 18, 2026 | WYSZOMIERSKI JACK LDirector | Option exercise | 20,634 | $407.93K | Form 4 |
| Feb 17, 2026 | MORRISSEY MICHAELPresident and CEO | Gift | 250,736 | — | Form 4 |
| Feb 17, 2026 | MORRISSEY MICHAELPresident and CEO | Gift | 250,736 | — | Form 4 |
| Feb 17, 2026 | Haley Patrick J.EVP, Commercial | Sale | 64,778 | $2.82M | Form 4 |
| Feb 17, 2026 | Haley Patrick J.EVP, Commercial | Sale | 3,036 | $133.10K | Form 4 |
| Feb 17, 2026 | Senner Christopher J.EVP and CFO | Sale | 30,617 | $1.34M | Form 4 |
| Feb 17, 2026 | Smith JulieDirector | Sale | 42,422 | $1.84M | Form 4 |
| Feb 17, 2026 | Smith JulieDirector | Option exercise | 42,422 | $771.66K | Form 4 |
| Feb 15, 2026 | Hefti BrendaSVP and General Counsel | Tax withholding | 5,430 | $238.49K | Form 4 |
| Feb 15, 2026 | Aftab DanaEVP, Research and Development | Tax withholding | 12,720 | $558.66K | Form 4 |
| Feb 15, 2026 | Aftab DanaEVP, Research and Development | Tax withholding | 26,485 | $1.16M | Form 4 |
| Feb 15, 2026 | MORRISSEY MICHAELPresident and CEO | Tax withholding | 120,390 | $5.29M | Form 4 |
| Feb 15, 2026 | Haley Patrick J.EVP, Commercial | Tax withholding | 31,483 | $1.38M | Form 4 |
| Feb 15, 2026 | Senner Christopher J.EVP and CFO | Tax withholding | 35,870 | $1.58M | Form 4 |
| Feb 13, 2026 | Eckhardt Sue GailDirector | Sale | 3,856 | $168.85K | Form 4 |
| Feb 13, 2026 | MORRISSEY MICHAELPresident and CEO | Tax withholding | 369,606 | $16.23M | Form 4 |
| Feb 13, 2026 | MORRISSEY MICHAELPresident and CEO | Option exercise | 494,700 | $10.54M | Form 4 |
| Feb 13, 2026 | Oliver BobDirector | Sale | 21,162 | $929.01K | Form 4 |
| Feb 13, 2026 | Oliver BobDirector | Sale | 9,088 | $396.33K | Form 4 |
| Feb 13, 2026 | Oliver BobDirector | Option exercise | 9,088 | $175.22K | Form 4 |
| Feb 13, 2026 | Senner Christopher J.EVP and CFO | Sale | 34,278 | $1.47M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4